Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused huge social and economic distress. Given its rapid spread and the lack of specific treatment options, SARS-CoV-2 needs to be inactivated according to strict biosafety measures during laboratory diagnostics and vaccine development. The inactivation method for SARS-CoV-2 affects research related to the natural virus and its immune activity as an antigen in vaccines. In this study, we used size exclusion chromatography, western blotting, ELISA, an electron microscope, dynamic light scattering, circular dichroism, and surface plasmon resonance to evaluate the effects of four different chemical inactivation methods on the physical and biochemical characterization of SARS-CoV...
Various types of COVID-19 vaccines, including adenovirus, mRNA, and inactivated ones, have been deve...
Many factors have been identified as having the ability to affect the sensitivity of rapid antigen d...
Objective: isolation of coronavirus SARS-CoV-2 from clinical sample of patient with COVID-19 in Novo...
Inactivated vaccines are promising tools for tackling the COVID-19 pandemic. We applied several prot...
The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, w...
Inactivation methods allow for hazard group 3 (HG3) pathogens to be disposed of and used safely in d...
Severe acute respiratory syndrome coronavirus-2 is the causative agent of COVID-19. During the pande...
Coronavirus (SARS-CoV-2) is a respiratory infection virus that was first detected in Wuhan, China. T...
The scientific community has responded to the coronavirus disease 2019 (COVID-19) pandemic by rapidl...
The scientific community has responded to the COVID-19 pandemic by rapidly undertaking research to f...
Background: Vaccination is the most effective tool for reducing the morbidity and mortality of COVID...
To enhance biosafety and reliability in SARS-CoV-2 molecular diagnosis, virus lysis/transport buffer...
The ongoing coronavirus 2019 (COVID-19) pandemic constitutes a concerning global threat to public he...
The etiological agent of severe acute respiratory syndrome (SARS) has been identified as a novel cor...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causing agent of the coronavirus d...
Various types of COVID-19 vaccines, including adenovirus, mRNA, and inactivated ones, have been deve...
Many factors have been identified as having the ability to affect the sensitivity of rapid antigen d...
Objective: isolation of coronavirus SARS-CoV-2 from clinical sample of patient with COVID-19 in Novo...
Inactivated vaccines are promising tools for tackling the COVID-19 pandemic. We applied several prot...
The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, w...
Inactivation methods allow for hazard group 3 (HG3) pathogens to be disposed of and used safely in d...
Severe acute respiratory syndrome coronavirus-2 is the causative agent of COVID-19. During the pande...
Coronavirus (SARS-CoV-2) is a respiratory infection virus that was first detected in Wuhan, China. T...
The scientific community has responded to the coronavirus disease 2019 (COVID-19) pandemic by rapidl...
The scientific community has responded to the COVID-19 pandemic by rapidly undertaking research to f...
Background: Vaccination is the most effective tool for reducing the morbidity and mortality of COVID...
To enhance biosafety and reliability in SARS-CoV-2 molecular diagnosis, virus lysis/transport buffer...
The ongoing coronavirus 2019 (COVID-19) pandemic constitutes a concerning global threat to public he...
The etiological agent of severe acute respiratory syndrome (SARS) has been identified as a novel cor...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causing agent of the coronavirus d...
Various types of COVID-19 vaccines, including adenovirus, mRNA, and inactivated ones, have been deve...
Many factors have been identified as having the ability to affect the sensitivity of rapid antigen d...
Objective: isolation of coronavirus SARS-CoV-2 from clinical sample of patient with COVID-19 in Novo...